Ohkuma & Colleagues employ #PDX models in #pancreatic cancer to find that Olfactomedin-4 is a chemoresistance-related marker of poor prognosis. #MedHighlight #pancreaticcancer #chemotherapyhttps://doi.org/10.1371/journal.pone.0226707 …
U tweetove putem weba ili aplikacija drugih proizvođača možete dodati podatke o lokaciji, kao što su grad ili točna lokacija. Povijest lokacija tweetova uvijek možete izbrisati. Saznajte više
Ohkuma & Colleagues employ #PDX models in #pancreatic cancer to find that Olfactomedin-4 is a chemoresistance-related marker of poor prognosis. #MedHighlight #pancreaticcancer #chemotherapyhttps://doi.org/10.1371/journal.pone.0226707 …